AU675481B2 - Antioxydant cardioprotective use of, and method of treatmentusing, hydroxycarbazole compounds - Google Patents

Antioxydant cardioprotective use of, and method of treatmentusing, hydroxycarbazole compounds

Info

Publication number
AU675481B2
AU675481B2 AU57322/94A AU5732294A AU675481B2 AU 675481 B2 AU675481 B2 AU 675481B2 AU 57322/94 A AU57322/94 A AU 57322/94A AU 5732294 A AU5732294 A AU 5732294A AU 675481 B2 AU675481 B2 AU 675481B2
Authority
AU
Australia
Prior art keywords
carbon atoms
formula
hydrogen
compound
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU57322/94A
Other languages
English (en)
Other versions
AU5732294A (en
Inventor
Frank C Barone
Giora Feuerstein
Tian-Li Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU5732294A publication Critical patent/AU5732294A/en
Application granted granted Critical
Publication of AU675481B2 publication Critical patent/AU675481B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paper (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
AU57322/94A 1992-12-01 1993-12-01 Antioxydant cardioprotective use of, and method of treatmentusing, hydroxycarbazole compounds Ceased AU675481B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98391692A 1992-12-01 1992-12-01
US983916 1992-12-01
PCT/US1993/011597 WO1994012177A1 (en) 1992-12-01 1993-12-01 Antioxydant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds

Publications (2)

Publication Number Publication Date
AU5732294A AU5732294A (en) 1994-06-22
AU675481B2 true AU675481B2 (en) 1997-02-06

Family

ID=25530177

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57322/94A Ceased AU675481B2 (en) 1992-12-01 1993-12-01 Antioxydant cardioprotective use of, and method of treatmentusing, hydroxycarbazole compounds

Country Status (9)

Country Link
US (1) US5405863A (enExample)
EP (1) EP0671913A1 (enExample)
JP (1) JPH08503710A (enExample)
KR (1) KR950703949A (enExample)
CN (1) CN1043509C (enExample)
AU (1) AU675481B2 (enExample)
CA (1) CA2150694A1 (enExample)
WO (1) WO1994012177A1 (enExample)
ZA (1) ZA938896B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000510110A (ja) * 1996-04-29 2000-08-08 スミスクライン・ビーチャム・コーポレイション 抗酸化化合物
WO1998015272A1 (en) 1996-10-09 1998-04-16 BOEHRINGER MANNHEIM PHARMACEUTICALS CORP. - SMITHKLINE BEECHAM CORPORATION, LIMITED PARTNERSHIP No.1 Method for inhibiting stress-activated protein kinases
JP4126345B2 (ja) * 1997-03-06 2008-07-30 松森　　昭 ウイルス感染症の予防・治療剤
US20020054911A1 (en) * 2000-05-11 2002-05-09 Boehringer Mannheim Pharmaceutical Corporation-Sm Ithkline Beckman Corporation, Limited Partnershi Novel oral dosage form for carvedilol
AU5251999A (en) 1998-08-04 2000-02-28 Wisconsin Alumni Research Foundation Method of reducing retinal ganglion cell degeneration
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US20050148779A1 (en) * 2002-04-30 2005-07-07 Wei Chen Carvedilol monocitrate monohydrate
US20050261355A1 (en) * 2002-06-27 2005-11-24 Sb Pharmco Puerto Rico Inc., Carvedilol hydobromide
KR101468827B1 (ko) * 2002-06-27 2014-12-03 스미스클라인 비이참 (코르크) 리미티드 카베딜롤 인산염 및(또는) 그의 용매화물, 상응하는 조성물, 및(또는) 치료 방법
US20050020666A1 (en) * 2003-07-25 2005-01-27 Dabur Research Foundation Cardioprotective agents
JP2007512350A (ja) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール組成物の治療および送達方法
EP1691789B1 (en) * 2003-11-25 2017-12-20 SmithKline Beecham (Cork) Limited Carvedilol free base, salts, anhydrous forms or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
EP1686986A4 (en) * 2003-11-25 2009-05-27 Sb Pharmco Inc CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT
US20090076116A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched carvediolo
US10281374B2 (en) * 2015-11-04 2019-05-07 Diagnostic Biosystems Method of pretreatment of biological samples for an analyte-staining assay method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503067A (en) * 1978-04-13 1985-03-05 Boehringer Mannheim Gmbh Carbazolyl-(4)-oxypropanolamine compounds and therapeutic compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438559A (en) * 1980-06-27 1984-03-27 Fuji Machine Mfg. Co. Ltd. Apparatus for automatically mounting non-lead electronic components on printed-circuit

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503067A (en) * 1978-04-13 1985-03-05 Boehringer Mannheim Gmbh Carbazolyl-(4)-oxypropanolamine compounds and therapeutic compositions

Also Published As

Publication number Publication date
US5405863A (en) 1995-04-11
CN1098909A (zh) 1995-02-22
WO1994012177A1 (en) 1994-06-09
CN1043509C (zh) 1999-06-02
ZA938896B (en) 1994-08-01
JPH08503710A (ja) 1996-04-23
AU5732294A (en) 1994-06-22
KR950703949A (ko) 1995-11-17
CA2150694A1 (en) 1994-06-09
EP0671913A1 (en) 1995-09-20
EP0671913A4 (enExample) 1995-10-25

Similar Documents

Publication Publication Date Title
AU675481B2 (en) Antioxydant cardioprotective use of, and method of treatmentusing, hydroxycarbazole compounds
JP4021507B2 (ja) プロリン含有医薬組成物
JPH07108855B2 (ja) 循環器治療薬として有用な酸化窒素―第一級アミン安定化コンプレックス
BG61678B1 (bg) Антиисхемично лекарствено средство
JP2852608B2 (ja) 口腔乾燥症治療剤
JP2002537258A5 (enExample)
HUE034007T2 (en) Treatment of atrial fibrillation
US20010011099A1 (en) Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds
US5508308A (en) Use of pyruvylglycine to treat ischemia/reperfusion injury following myocardial infarction
EP1006793B1 (en) Anti-arrhythmic composition and methods of treatment
AU673882B2 (en) Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds
US9125877B2 (en) Use of kauranes compounds in the manufacture of medicament
EP0543855A1 (en) Use of aryl hydroxyurea compounds for the treatment of atherosclerosis
EP0907318A1 (en) Antioxidant compound
JP2893903B2 (ja) 虚血―再灌流障害予防、治療剤
HU208004B (en) Process for producing ascorbinic acid derivatives and pharmaceutical compositions containing them
EP1311486B1 (en) Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same
IE900306A1 (en) Agent for use in the prevention, control or reversal of¹hypertension
EP0474438A1 (en) Method for preventing or treating cerebrovascular disease employing the ACE-inhibitor ceronapril
JPH0576925B2 (enExample)
EA003470B1 (ru) Фармацевтическая композиция тгп и ингибитора апф
Mayrleitner E047/1
CA1256031A (en) Pharmaceutical compositions containing diltiazem and alfuzosin
Jaffe Use of intravenous diltiazem in patients with acute coronary artery disease
US4716177A (en) Tolrestat for inhibition of weight gain